Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 25133641)

1.

The appropriateness of more intensive colonoscopy screening than recommended in Medicare beneficiaries: a modeling study.

van Hees F, Zauber AG, Klabunde CN, Goede SL, Lansdorp-Vogelaar I, van Ballegooijen M.

JAMA Intern Med. 2014 Oct;174(10):1568-76. doi: 10.1001/jamainternmed.2014.3889.

2.

Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.

Dinh T, Ladabaum U, Alperin P, Caldwell C, Smith R, Levin TR.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1158-66. doi: 10.1016/j.cgh.2013.03.013. Epub 2013 Mar 28.

PMID:
23542330
3.

Cancer screening rates in individuals with different life expectancies.

Royce TJ, Hendrix LH, Stokes WA, Allen IM, Chen RC.

JAMA Intern Med. 2014 Oct;174(10):1558-65. doi: 10.1001/jamainternmed.2014.3895.

PMID:
25133746
4.

Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.

Sharaf RN, Ladabaum U.

Am J Gastroenterol. 2013 Jan;108(1):120-32. doi: 10.1038/ajg.2012.380. Epub 2012 Dec 18.

PMID:
23247579
5.

Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals.

Ladabaum U, Mannalithara A, Jandorf L, Itzkowitz SH.

Cancer. 2015 Apr 1;121(7):1088-97. doi: 10.1002/cncr.29162. Epub 2014 Dec 9.

PMID:
25492455
6.

Rescreening of persons with a negative colonoscopy result: results from a microsimulation model.

Knudsen AB, Hur C, Gazelle GS, Schrag D, McFarland EG, Kuntz KM.

Ann Intern Med. 2012 Nov 6;157(9):611-20. doi: 10.7326/0003-4819-157-9-201211060-00005.

7.

Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.

Dinh TA, Alperin P, Walter LC, Smith R.

J Gen Intern Med. 2012 Jun;27(6):730-8. doi: 10.1007/s11606-011-1972-6. Epub 2012 Jan 12. Review.

8.

Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis.

van Hees F, Habbema JD, Meester RG, Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG.

Ann Intern Med. 2014 Jun 3;160(11):750-9. doi: 10.7326/M13-2263.

9.

Cost-effectiveness of screening for colorectal cancer in the general population.

Frazier AL, Colditz GA, Fuchs CS, Kuntz KM.

JAMA. 2000 Oct 18;284(15):1954-61.

PMID:
11035892
10.

Age-based and sex-based disparities in screening colonoscopy use among medicare beneficiaries.

Gancayco J, Soulos PR, Khiani V, Cramer LD, Ross JS, Genao I, Tinetti M, Gross CP.

J Clin Gastroenterol. 2013 Aug;47(7):630-6. doi: 10.1097/MCG.0b013e31828345c8.

PMID:
23619827
11.

Limited life expectancy among a subgroup of medicare beneficiaries receiving screening colonoscopies.

Mittal S, Lin YL, Tan A, Kuo YF, El-Serag HB, Goodwin JS.

Clin Gastroenterol Hepatol. 2014 Mar;12(3):443-450.e1. doi: 10.1016/j.cgh.2013.08.021. Epub 2013 Aug 22.

12.

Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.

Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, Savarino JE, van Ballegooijen M, Kuntz KM, Zauber AG.

J Natl Cancer Inst. 2010 Aug 18;102(16):1238-52. doi: 10.1093/jnci/djq242. Epub 2010 Jul 27.

13.

Self-reported colorectal cancer screening of Medicare beneficiaries in family medicine vs. internal medicine practices in the United States: a cross-sectional study.

Higgins AY, Doubeni AR, Phillips KL, Laiyemo AO, Briesacher B, Tjia J, Doubeni CA.

BMC Gastroenterol. 2012 Mar 21;12:23. doi: 10.1186/1471-230X-12-23.

14.

Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer.

Gross CP, Andersen MS, Krumholz HM, McAvay GJ, Proctor D, Tinetti ME.

JAMA. 2006 Dec 20;296(23):2815-22.

PMID:
17179458
15.

Minimal benefit of earlier-than-recommended repeat colonoscopy among US Medicare enrollees following a negative colonoscopy.

Yang YX, French B, Localio AR, Brensinger CM, Lewis JD.

Aliment Pharmacol Ther. 2014 Oct;40(7):843-53. doi: 10.1111/apt.12902. Epub 2014 Aug 14.

PMID:
25123489
16.

Screening based on risk for colorectal cancer is the most cost-effective approach.

Dan YY, Chuah BY, Koh DC, Yeoh KG.

Clin Gastroenterol Hepatol. 2012 Mar;10(3):266-71.e1-6. doi: 10.1016/j.cgh.2011.11.011. Epub 2011 Nov 16.

PMID:
22100624
17.

Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?

Schneider EC, Rosenthal M, Gatsonis CG, Zheng J, Epstein AM.

Med Care. 2008 Sep;46(9 Suppl 1):S84-90. doi: 10.1097/MLR.0b013e31817fdf80.

PMID:
18725838
18.

Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic region.

Sheffield KM, Han Y, Kuo YF, Riall TS, Goodwin JS.

JAMA Intern Med. 2013 Apr 8;173(7):542-50. doi: 10.1001/jamainternmed.2013.2912.

19.

Assessing the impact of screening colonoscopy on mortality in the medicare population.

Gross CP, Soulos PR, Ross JS, Cramer LD, Guerrero C, Tinetti ME, Braithwaite RS.

J Gen Intern Med. 2011 Dec;26(12):1441-9. doi: 10.1007/s11606-011-1816-4. Epub 2011 Aug 13.

20.

Use of preventive services by Medicare fee-for-service beneficiaries: does spillover from managed care matter?

Koroukian SM, Litaker D, Dor A, Cooper GS.

Med Care. 2005 May;43(5):445-52.

PMID:
15838408
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk